Contact this trialFirst, we need to learn more about you.
ATR Kinase Inhibitor
Lurbinectedin + Berzosertib for Small Cell Lung Cancer
Recruiting1 awardPhase 1 & 2
Bethesda, Maryland
This trial is testing a combination of drugs to see if they may be effective in shrinking tumors for people with small cell lung cancer or high-grade neuroendocrine cancers.
Fill-in a few details and create your profileSave answers to your profile & unlock recommendations.
We will keep your details privateWe won't share unless you give us permission. By completing this form you agree to our privacy policy and terms of service.
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.
By clicking start, you agree to our
terms of service